FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Qualitest Pharmaceuticals Promethazine Vc With Codeine Syrup Recall

PROMETHAZINE VC WITH CODEINE SYRUP, EACH 5 ml contains: Codeine Phosphate 10 mg, Prome…

Qualitest Pharmaceuticals · Huntsville, AL

Risk level
Class III
Reported by FDA
Apr 15, 2015
Recall ID
D00432-2015
Check your lot numberHow we source this data

Summary

Qualitest Pharmaceuticals recalled Promethazine Vc With Codeine Syrup starting Mar 25, 2015. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D00432-2015 on Apr 15, 2015. Reason: Failed Impurities/Degradation Specifications: A stability lot was out of specification for a known impurity at the 8 month Controlled Room Temperature stability time-point. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: A stability lot was out of specification for a known impurity at the 8 month Controlled Room Temperature stability time-point.

Product description

PROMETHAZINE VC WITH CODEINE SYRUP, EACH 5 ml contains: Codeine Phosphate 10 mg, Promethazine Hydrochloride 6.25 mg, Phenylephrine Hydrochloride 5 mg, alcohol 7%, (a) 4 fl oz bottle (NDC 0603-1588-54) and (b) 16 fl oz bottle (NDC 0603-1588-58) Rx only, Manufactured for QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811.

Lot numbers, UPCs & expiration codes

Lot #: (a) L073D14A, Exp 07/31/15. Lot #: (b) L073D14B, Exp 07/31/15; 0000002247, Exp 03/31/16; L063B14A, Exp 05/31/15

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D00432-2015
Classification
Class III
Status
Terminated
Recall initiated
Mar 25, 2015
FDA report date
Apr 15, 2015
Quantity
36,732 units
Recall type
Voluntary: Firm initiated
Recalling firm
Qualitest Pharmaceuticals

Original FDA data

Every field from FDA enforcement report D00432-2015, exactly as published.

Show all FDA fields
City
Huntsville
State
AL
Status
Terminated
Country
United States
Event ID
70852
Address
120 Vintage Dr NE
Code information
Lot #: (a) L073D14A, Exp 07/31/15. Lot #: (b) L073D14B, Exp 07/31/15; 0000002247, Exp 03/31/16; L063B14A, Exp 05/31/15
Postal code
35811-8216
Report date
Apr 15, 2015
Product type
Drugs
Recall number
D00432-2015
Classification
Class III
Recalling firm
Qualitest Pharmaceuticals
Product quantity
36,732 units
Termination date
Jul 12, 2016
Reason for recall
Failed Impurities/Degradation Specifications: A stability lot was out of specification for a known impurity at the 8 month Controlled Room Temperature stability time-point.
Voluntary / mandated
Voluntary: Firm initiated
Product description
PROMETHAZINE VC WITH CODEINE SYRUP, EACH 5 ml contains: Codeine Phosphate 10 mg, Promethazine Hydrochloride 6.25 mg, Phenylephrine Hydrochloride 5 mg, alcohol 7%, (a) 4 fl oz bottle (NDC 0603-1588-54) and (b) 16 fl oz bottle (NDC 0603-1588-58) Rx only, Manufactured for QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811.
Distribution pattern
Nationwide
Recall initiation date
Mar 25, 2015
Initial firm notification
Letter
Center classification date
Apr 6, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D00432-2015, published Apr 15, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls